Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia.
about
Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy.Immunotherapy-associated autoimmune hemolytic anemia.Pembrolizumab-Induced Pancytopenia: A Case ReportNivolumab-induced aplastic anemia: A case report and literature review.Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström Macroglobulinemia.Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab
P2860
Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@en
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@nl
type
label
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@en
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@nl
prefLabel
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@en
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@nl
P2093
P2860
P356
P1476
Development of Hemolytic Anemi ...... nd Chronic Lymphatic Leukemia.
@en
P2093
G Kristiansen
K S Schwab
P Brossart
P2860
P304
P356
10.1159/000447508
P577
2016-05-01T00:00:00Z